<code id='916130BBE9'></code><style id='916130BBE9'></style>
    • <acronym id='916130BBE9'></acronym>
      <center id='916130BBE9'><center id='916130BBE9'><tfoot id='916130BBE9'></tfoot></center><abbr id='916130BBE9'><dir id='916130BBE9'><tfoot id='916130BBE9'></tfoot><noframes id='916130BBE9'>

    • <optgroup id='916130BBE9'><strike id='916130BBE9'><sup id='916130BBE9'></sup></strike><code id='916130BBE9'></code></optgroup>
        1. <b id='916130BBE9'><label id='916130BBE9'><select id='916130BBE9'><dt id='916130BBE9'><span id='916130BBE9'></span></dt></select></label></b><u id='916130BBE9'></u>
          <i id='916130BBE9'><strike id='916130BBE9'><tt id='916130BBE9'><pre id='916130BBE9'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:18699
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          ASCO Takeaways: Winners, snoozers, and the art of cancer care
          ASCO Takeaways: Winners, snoozers, and the art of cancer care

          ThousandsofoncologistsbadeChicagoagoodnight.ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30S

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          National panel will explore requiring free Covid tests

          TheU.S.PreventiveServicesTaskForcewilldiscussrecommendingCovid-19screening,thefirststepinrequiringin